PURLs

Bariatric surgery + medical therapy: Effective Tx for T2DM?

Author and Disclosure Information

 

References

Due to the small sample size of the study, it is unclear if the outcomes of the 2 surgery groups were significantly different. Patients who received gastric bypass surgery had more weight loss and used less diabetes medication at the end of follow-up compared with the patients who received sleeve gastrectomy. More information is needed to determine which gastric surgery is preferable for the treatment of T2DM while minimizing adverse effects. However, both of the procedures had outcomes superior to that with IMT, and selection of a particular type of surgery should be a joint decision between the patient and provider.

CHALLENGES TO IMPLEMENTATION

Access and cost may be barriers

The major barriers to implementation are access to, and the cost of, bariatric surgery.

ACKNOWLEDGEMENT

The PURLs Surveillance System was supported in part by Grant Number UL1RR024999 from the National Center For Research Resources, a Clinical Translational Science Award to the University of Chicago. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health.

Pages

Copyright © 2019. The Family Physicians Inquiries Network. All rights reserved.

Online-Only Materials

AttachmentSize
PDF icon jfp06802104_methodology190.74 KB

Recommended Reading

New diabetes drugs solidify their cardiovascular and renal benefits
Journal of Clinical Outcomes Management
Researchers exploring ways to mitigate aging’s impact on diabetes
Journal of Clinical Outcomes Management
Torrent Pharmaceuticals expands losartan recall
Journal of Clinical Outcomes Management
Does reduced degradation of insulin by the liver cause type 2 diabetes?
Journal of Clinical Outcomes Management
SGLT-2 inhibitors promising for heart failure prevention, not treatment
Journal of Clinical Outcomes Management
Gastric Electric Stimulation for Refractory Gastroparesis
Journal of Clinical Outcomes Management
Intensive insulin added no benefit for hyperglycemia after ischemic stroke
Journal of Clinical Outcomes Management
SGLT2 inhibitors morph into HF drugs
Journal of Clinical Outcomes Management
AACE/ACE algorithm provides practical clinical guidance on managing diabetes
Journal of Clinical Outcomes Management
FDA clears first-of-its-kind phone app for insulin management
Journal of Clinical Outcomes Management